Miao Wang

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

British journal of pharmacology

Circulation research

Nature communications

Journal of cellular and molecular medicine

Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital

Chinese Academy of Medical Sciences and Peking Union Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital

China

Professor of Pharmacology :: State Key Laboratory of Cardiovascular Disease

Pfizer Global Research and Development

United States

Principal Scientist :: Cardiovascular and Metabolic Disease Research Unit

University of Pennsylvania

United States

Research Assistant Professor :: Pharmacology

University of Pennsylvania

United States

Research Associate :: Pharmacology

Education History

Chinese Academy of Medical Sciences and Peking Union Medical College

China

PHD :: Institute of Basic Medical Sciences

Publications

Yurong Zhang, Zengrong Chen, Junyan Guo, Qing Wan, Yingjie Zhang, Huihui Li, Haojie Rao, Jianfeng Yang, Pengfei Xu, Hong Chen, Miao Wang
Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice. British journal of pharmacology 181 (19) (2024)
Pengfei Xu, Yingjie Zhang, Junyan Guo, Huihui Li, Sandra Konrath, Peng Zhou, Liming Cai, Haojie Rao, Hong Chen, Jian Lin, Zhao Cui, Bingyang Ji, Jianwei Wang, Chunyang Li, De-Pei Liu, Thomas Renné, Miao Wang
A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation. Nature communications 15 (1) (2024)
Yurong Zhang, Zengrong Chen, Junyan Guo, Qing Wan, Yingjie Zhang, Huihui Li, Haojie Rao, Jianfeng Yang, Pengfei Xu, Hong Chen, Miao Wang
Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice. British journal of pharmacology (2024)
Yuze Zhang, Julia Steinmetz-Späh, Helena Idborg, Liyuan Zhu, Huihui Li, Haojie Rao, Zengrong Chen, Ziyi Guo, Lejia Hu, Chuansheng Xu, Hong Chen, Marina Korotkova, Per-Johan Jakobsson, Miao Wang
Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodeling after myocardial infarction in mice. British journal of pharmacology (2023)
Yuze Zhang, Julia Steinmetz-Späh, Helena Idborg, Liyuan Zhu, Huihui Li, Haojie Rao, Zengrong Chen, Ziyi Guo, Lejia Hu, Chuansheng Xu, Hong Chen, Marina Korotkova, Per-Johan Jakobsson, Miao Wang
Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice. British journal of pharmacology (2023)
Qing Wan, Chuansheng Xu, Liyuan Zhu, Yuze Zhang, Zekun Peng, Hong Chen, Haojie Rao, Erli Zhang, Hongyue Wang, Fei Chu, Xuan Ning, Xuejian Yang, Jinqing Yuan, Yongjian Wu, Yu Huang, Shengshou Hu, De-Pei Liu, Miao Wang
Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation. Circulation research 131 (5) (2022)
Yuanjun Tang, Yiting Jia, Linwei Fan, Han Liu, Yuan Zhou, Miao Wang, Yuefeng Liu, Juanjuan Zhu, Wei Pang, Jing Zhou
MFN2 Prevents Neointimal Hyperplasia in Vein Grafts via Destabilizing PFK1. Circulation research 130 (11) (2022)
Huifeng Hao, Xiaoyan Ma, Hong Chen, Liyuan Zhu, Zhenyu Xu, Qiaoling Li, Chuansheng Xu, Yuze Zhang, Zekun Peng, Miao Wang
The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice. Journal of cellular and molecular medicine 24 (17) (2020)
Liyuan Zhu, Chuansheng Xu, Xingyu Huo, Huifeng Hao, Qing Wan, Hong Chen, Xu Zhang, Richard M Breyer, Yu Huang, Xue-Tao Cao, De-Pei Liu, Garret A FitzGerald, Miao Wang
The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury. Nature communications 10 (1) (2019)

Miao Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miao Wang